Abstract
The allogeneic therapeutic vaccine CSF-470 has demonstrated a significant benefit over medium-dose IFNα2b in the distant metastasis-free survival for stages IIB-IIC-III cutaneous melanoma patients in a randomized phase II/III clinical trial (CASVAC-0401, NCT01729663). At the end of the 2-year CSF-470 immunization protocol, patient #006 developed several lung and one subcutaneous melanoma metastases; this later was excised. In this report, we analyzed the changes throughout vaccination of immune populations in blood and in the tumor tissue, with special focus on the T-cell repertoire. Immunohistochemistry revealed a marked increase in CD8+, CD4+, and CD20+ lymphocytes infiltrating the metastasis relative to the primary tumor. Lymphocytes were firmly attached to dying-tumor cells containing Granzyme-B granules. Whole-exon sequencing assessment indicated a moderate-to-high tumor mutational burden, with BRAFV600E as the main oncogenic driver. Mutational signature presented large numbers of mutations at dipyrimidines, typical of melanoma. Relevant tumor and immune-related genes from the subcutaneous metastasis were addressed by RNA-Seq analysis, revealing expression of typical melanoma antigens and proliferative tumor-related genes....Continue Reading
References
Apr 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Danila ValmoriPierre-Yves Dietrich
Mar 31, 2004·Cancer Cell·Natalia RubinsteinGabriel A Rabinovich
Dec 21, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Begoña Comin-AnduixAntoni Ribas
Sep 29, 2011·Immunity·Ben YoungbloodRafi Ahmed
Dec 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chengwen LiuPatrick Hwu
Mar 29, 2014·The Journal of Clinical Investigation·Alena GrosSteven A Rosenberg
Sep 26, 2014·Cancer Immunology Research·David L BajorRobert H Vonderheide
Feb 19, 2015·Cancer Immunology Research·Theodore KouoElizabeth Jaffee
Apr 4, 2015·Science·Beatriz M CarrenoGerald P Linette
Sep 26, 2015·Molecular Oncology·Ilan KirschHarlan Robins
May 7, 2016·Science·Christian U BlankTon N Schumacher
Dec 3, 2016·Oncotarget·Benjamin E PaluchCarl D Morrison
Apr 12, 2017·Nature·Alexander C HuangE John Wherry
Jun 18, 2017·Frontiers in Immunology·José MordohMaría Marcela Barrio
Jun 22, 2017·Nature·Pradyot DashPaul G Thomas
Sep 8, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shravan MadireddiMichael Croft
Oct 4, 2017·Frontiers in Immunology·Mariana ArisMaría Marcela Barrio
Jan 4, 2018·Oncoimmunology·Sylvain Simon, Nathalie Labarriere
Citations
May 29, 2019·Melanoma Research·Cindy L ZulegerMark R Albertini
Nov 20, 2018·Frontiers in Immunology·María B PampenaJosé Mordoh
Jun 26, 2020·Frontiers in Immunology·Enrique PodazaMaría Marcela Barrio
Sep 27, 2019·Frontiers in Immunology·Esteban LanzarottiMorten Nielsen
Oct 18, 2019·Frontiers in Immunology·Mariana ArisJosé Mordoh
Apr 8, 2020·Frontiers in Cell and Developmental Biology·Aleksandra FilipovicJoseph Bolen
Aug 28, 2020·Frontiers in Genetics·Qingshan NiYing Wan
Jul 11, 2021·International Reviews of Immunology·Ronghua SongJin-An Zhang